宗成利 博士 教授 博士生导师
联系方式:海南省海口市人民大道58号伟德bv1946官网药学系,570228
邮箱:chengli.zong@hainanu.edu.cn
课题组:https://the_ring.gitee.io/zong-introduction/
1.教育及工作背景
2020.10-至今 伟德bv1946官网 教授
2016.08-2020.10 默沙东制药公司-美国费城 高级科学家
2010.09-2016.05乔治亚大学(university of Georgia)-复杂碳水化合物研究中心(Complex Carbohydrate Research Center)(博士)
2007.09-2010.07中国海洋大学-伟德bv1946官网(硕士)
2003.09-2007.07中国海洋大学-伟德bv1946官网(本科)
2.科研情况
细菌疫苗新策略,新型肿瘤疫苗,疫苗佐剂活性增强研究
伟德bv1946官网-迈科康生物科技有限公司“先进疫苗研究联合实验室”-负责人
BV伟德国际1946-糖类小分子药物及多糖疫苗研究创新团队-负责人
3.研究领域
多糖疫苗,免疫学,药物化学,糖化员工物学
4.代表性项目
(1)肿瘤疫苗
新型原位肿瘤疫苗,基于肿瘤表面特殊抗原的亚单位疫苗。
(2)针对超级耐药菌的多糖疫苗研究
作为肺炎球菌多糖领域的行业专家,参与了默沙东下一代肺炎球菌疫苗的开发:例如细菌的发酵,荚膜多糖的分离,纯化,活化,与CRM197偶联等。参与研究的默沙东多价肺炎球菌结合型疫苗研发V114和V116项目已经进入临床实验。
(3)糖胺聚糖的化员工物学研究
建立了一种可以快速合成糖胺聚糖类化合物的保护基以及纯化策略,为此类化合物的构效关系研究奠定了基础。领导并完成了以下项目:建立了一个硫酸肝素四糖化合物库,通过微阵列筛选,发现了一系列硫酸肝素结合蛋白的底物特点;发现了一个在神经导向过程中起重要作用的硫酸肝素八糖结构;发现了一种可以修饰哺乳动物细胞表面的新方法;确定了肿瘤细胞表面一种特殊的硫酸软骨素A。
5.代表性成果
1)Teng, C-C.; Zong, C. *, “Self-assembled TLR7/8 agonist-mannose conjugate as an effective vaccine adjuvant for SARS-CoV-2 RBD trimer”, Polymers, 2022, 14, 5466 IF=4.967
2)Sun, T.; Mai, S-Y.; Mao, H-Z.; Li, H-T.; Duan, Y-Y.; Meng, S.; Bao, J-L.; Ding, N.; Zong, C.*, “Conjugate of Structurally Reassigned Pneumococcal Serotype 31 Polysaccharide with CRM197 Elicited Potent Immune Response.” Carbohydrate Polymers, 2022, 289, 119414 IF=10.72
3)Li, H-T.; Chen, C.; Mao, H-Z.; Xu, Y.; Meng, S.; Sun, T-T.; Zong, C. *, Efficient synthesis of α-galactosylceramide and its C-6 modified analogues, Frontiers in Chemistry, 2022, 1451 IF=5.221
4)Wan, Y.;* Zong, C.;*(共一) Li, X-P.; Wang, A.; Rodrigo, L-A.; Mao, C-B., “New Insights for Biosensing: Lessons from Microbial Defense System.” Chemical Reviews, 2022, 122, 8126-8180 IF=72.087
5)Zong, C.; Fang, L.; Song, F.; Wang, A.; Wan, Y., “Fluorescent Fingerprint Bacteria by Multi-channel Magnetic Fluorescent Nanosensor.” Sensors and Actuators B: Chemical. 2019, 289, 234-241. IF=9.221
6)Zong, C.; Venot, A., Li, X.; Lu, W; Xiao, W.; Wilkes, J-W; Salanga, C-L.; Handel, T-M.; Wang, L.; Wolfert, M-A.; Boons, G-J., “A Heparan Sulfate Microarray Reveals that Heparan Sulfate-Protein Binding Exhibit Different Ligand Requirements.” Journal of the American Chemical Society, 2017, 139, 9534-9543 IF=16.38
7)Zong, C.; Huang, R.; Condac, E.; Chiu, Y.; Xiao, W.; Li, X.; Lu, W.; Ishihara, M.; Wang, S.; Ramiah, A.; Stickney, M.; Azadi, P.; Amster, I-J.; Moremen, K-W.; Wang, L.; Sharp, J-S.; Boons, G-J., “Integrated Approach to Identify Heparan Sulfate Ligand Requirements of Robo1.” Journal of the American Chemical Society, 2016, 138, 13059-13067 IF=16.38
8)Zong, C.; Venot, A.; Dhamale, O-P.; Boons, G-J., “Fluorous supported modular synthesis of heparan sulfate oligosaccharides” Org. Lett., 2013, 15, 342–345. IF=16.38
9)Zong, C.; Li, Z.; Sun, T.; Wang, P.; Li, Y., “Convenient Synthesis of Sulfated Oligofucosides” Carbohydr. Res. 2010. 11, 1522-1532. IF=2.975
10)Lu, W.; Zong, C.; Liu, J.; Boons, G-J., “Controlled chemoenzymatic synthesis of heparan sulfate oligosaccharide.” Angewandte Chemie, 2018, 57, 5340-5344.
11)Yi, F.; Hong, X.; Kumar, A.B.; Zong, C.; Boons, G-J.; Scott, C.R.; Turecek, F.; Robinson, B.H.; Gelb, M.H., “Detection of mucopolysaccharidosis III-A (Sanfilippo Syndrome-A) in dried blood spots (DBS) by tandem mass spectrometry.” Molecular Genetics and Metabolism, 2018, 125, 59-63.
12)Moure, M.J.; Eletsky, A.; Gao, Q.; Morris, L.C.; Yang, J.Y.; Chapla, D.; Zhao, Y.; Zong, C.; Amster, I.J.; Moremen, K.W.; Boons, G-J., “Paramagnetic Tag for Glycosylation Sites in Glycoproteins: Structural Constraints on Heparan Sulfate Binding to Robo1.” ACS chemical biology, 2018, 13, 2560-2567.
13)Capicciotti, C. J., Zong, C., Sheikh, M. O., Sun, T., Wells, L., & Boons, G-J. "Cell-Surface Glyco-Engineering by Exogenous Enzymatic Transfer using a Bi-Functional CMP-Neu5Ac Derivative." Journal of the American Chemical Society, 2017, 139, 13342-13348.
14)Agyekum, I.; Zong, C.; Boons, G-J.; Amster, I-J, “Single Stage Tandem Mass Spectrometry Assignment of the C-5 Uronic Acid Stereochemistry in Heparan Sulfate Tetrasaccharide using Electron Detachment Dissociation” Journal of the American Society for Mass Spectrometry, 2017, 29, 1-10.
15)Zhao, Y.; Singh, A.; Xu, Y.; Zong, C.; Zhang, F.; Boons, G.J.; Liu, J.; Linhardt, R.J.; Woods, R.J.; Amster, I.J., “A Traveling Wave Ion Mobility Spectrometry (TWIMS) Study of the Robo1-Heparan Sulfate Interaction” Journal of the American Society for Mass Spectrometry, 2017, 28, 96-109.
16)Huang, R.; Zong, C.; Venot A.; Chiu, Y.; Zhou, D.; Boons G-J.; Sharp, J., "The de novo Sequencing of Complex Mixtures of Heparan Sulfate Oligosaccharides” Analytical Chemistry, 2016, 88, 5299-5307
17)Gao, Q.; Chen, C.Y.; Zong, C.; Wang, S.; Ramiah, A.; Prabhakar, P.; Morris, L.C.; Boons, G.J.; Moremen, K.W.; Prestegard, J.H., “Structural Aspects of Heparan Sulfate Binding to Robo1–Ig1–2” ACS Chemical Biology, 2016, 11, 3106-3113.
18)Agyekum, I.; Patel, A-B.; Zong, C.; Boons, G-J.; Amster, J., “Assignment of Hexuronic Acid Stereochemistry in Synthetic Heparan Sulfate Tetrasaccharides with 2-O-sulfo Uronic Acids Using Electron Detachment Dissociation” International Journal of Mass Spectrometry, 2015, 390, 163-169.
19)Huang, Y.; Mao, Y.; Zong, C.; Lin, C.; Boons, G-J.; Zaia, J., “Discovery of a Heparan Sulfate 3-O-Sulfation Specific Peeling Reaction” Analytical Chemistry, 2015, 87, 592-600.
20)Hu, H.; Huang, Y.; Mao, Y.; Yu, X.; Xu, Y.; Liu, J.; Zong, C.; Boons, G-J.; Zaia, J., “A Computational Framework for Heparan Sulfate Sequencing Using High-resolution Tandem Mass Spectra” Molecular & Cellular Proteomics, 2014, 13, 2490-2502.
21)Dhamale, O-P.; Zong, C.; Al-Mafraji, K.; Boons, G-J., “New Glucuronic Acid Donors for the Modular Synthesis of Heparan Sulfate Oligosaccharides” Organic & Biomolecular Chemistry, 2014, 12, 2087-2098.
22)Zhang, Z.; Zong, C.; Song, G.; Lv, G.; Chun, Y.; Wang, P.; Ding, N.; Li, Y., “Total Synthesis of Caminoside B, a Novel Antimicrobial Glycolipid Isolated from the Marine Sponge Caminus Sphaeroconia” Carbohydr. Res. 2010, 6, 750-760.
23)Sun, T.; Zhang, W.; Zong, C.; Wang, P.; Li, Y., “First Total Synthesis and Stereochemical Reassignment of Tasiamide B” J. of Pept. Sci. 2010, 16, 364-374.